Ponnusamy, S.Coss, C.Thiyagarajan, T.Watts, K.Hwang, D.-J.He, Y.Selth, L.McEwan, I.Duke, C.Pagadala, J.Singh, G.Wake, R.Ledbetter, C.Tilley, W.Moldoveanu, T.Dalton, J.Miller, D.Narayanan, R.2019-06-262019-06-262017Cancer Research, 2017; 77(22):6282-62980008-54721538-7445http://hdl.handle.net/2440/119732Abstract not availableen© 2017 American Association for Cancer Research.Cell Line, TumorAnimalsMice, Inbred NODMice, KnockoutHumansMice, SCIDAnilidesIndolesReceptors, AndrogenXenograft Model Antitumor AssaysGene Expression ProfilingCell ProliferationGene Expression Regulation, NeoplasticAlternative SplicingMolecular StructureMaleAndrogen Receptor AntagonistsProstatic Neoplasms, Castration-ResistantNovel selective agents for the degradation of androgen receptor variants to treat castration-resistant prostate cancerJournal article003007645810.1158/0008-5472.can-17-09760004151079000212-s2.0-85033771016371509Selth, L. [0000-0002-4686-1418]Tilley, W. [0000-0003-1893-2626]